Form 4: TransMedics Group Executive Anil P. Ranganath Reports Stock Transactions

Anil P. Ranganath, a Senior Vice President at TransMedics Group, reported the sale and acquisition of company stock, including transactions related to tax obligations and an employee stock purchase plan.

Summary

• Anil P. Ranganath, a Senior Vice President at TransMedics Group, filed a Form 4 detailing changes in beneficial ownership.
• On June 5, 2024, Ranganath sold 703 shares of common stock at $135.21 per share to cover tax withholding obligations related to vesting restricted stock units.
• On August 7, 2024, Ranganath exercised a stock option to acquire 4,289 shares at $93.88 per share.
• Also on August 7, 2024, Ranganath sold 4,289 shares at $152.2 per share.
• Ranganath acquired 84 shares on June 28, 2024, through the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan (ESPP) at a price equal to 85% of the closing price of Issuer's Common Stock on January 2, 2024.
• Following these transactions, Ranganath directly owns 8,893 shares of common stock and holds options for 10,420 shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.

Positives

• The executive's participation in the Employee Stock Purchase Plan indicates confidence in the company's future.
• The exercise of stock options suggests a belief in the potential for future stock price appreciation.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may be interested in the trading activity of company executives as an indicator of their confidence in the company's prospects.

Key Dates